Added by | llasorsa |
---|---|
Group name | EquipeMY |
Item Type | Attachment |
Title | Texte intégral |
URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.00601 |
Accessed | 2022/08/30 - 18:19:33 |
Date Added | 2022/08/30 - 16:19:33 |
Date Modified | 2022/08/30 - 16:19:33 |
Parent item | Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181 |